Commemorative Issue Celebrating the 20th Anniversary of the Alzheimer’s Foundation of America: Understanding and Treating Alzheimer’s Disease

Dear Colleagues, 

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by acognitive decline affecting memory, planning, problem-solving, language, and activities of daily living. Hallmarks of the disease are the accumulation of amyloid-β peptide and hyperphosphorylated tau protein in the brain. Unfortunately, immune-based therapies targeting these proteins have been disappointing, and there is no cure. The principal risk factor for AD is age, and as the population grows older, the global prevalence will increase dramatically. AD is, therefore, an urgent public health problem.

In this Special Issue, we encourage the submission of manuscripts on any aspect of AD diagnosis, pathogenesis and treatment. We welcome original studies, reviews, and opinion articles. This Special Issue will focus on hot topics related to AD, bring in experts in the field to discuss current therapeutic approaches, as well as novel treatments under development. The diagnosis, predictive tools and molecular mechanisms of disease pathophysiology are also of great interest. The importance of lifestyle factors such as diet and physical activity is also recognized. This Special Issue in honor of the 20th Anniversary of the Alzheimer’s Foundation of America will provide a state-of-the-art overview of this subject, which will serve as a valued point of reference for geriatricians, neurologists, internal medicine physicians, psychiatrists, neuroscientists, molecular biologists and healthcare workers.

Dr. Allison B. Reiss
Dr. Aaron Pinkhasov
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.